Outcomes of digoxin vs. beta blocker in atrial fibrillation: report from ESC–EHRA EORP AF Long-Term General Registry — Wern Yew Ding (2021) | RDL Network
Outcomes of digoxin vs. beta blocker in atrial fibrillation: report from ESC–EHRA EORP AF Long-Term General Registry
Article 2021 en
Authors
WD
Wern Yew Ding
GB
Giuseppe Boriani
FM
Francisco Marı́n
Abstract
1 min read
Poor outcomes related to the use of digoxin over beta-blocker therapy in terms of excess mortality and reduced quality of life are associated with the presence of other risk factors rather than digoxin per se. The choice of digoxin or beta-blocker therapy had no influence on the incidence of unplanned hospitalizations.
Wern Yew Ding, Agnieszka Kotalczyk, Giuseppe Boriani, Francisco Marı́n, Carina Blomström‐Lundqvist, Tatjana Potpara, Laurent Fauchier, Professor Gregory Lip, Giuseppe Boriani, G Y H Lip, L. Tavazzi, Aldo P. Maggioni, G.-A. Dan, Tatjana Potpara, Michael Näbauer, Francisco Marı́n, Zbigniew Kalarus, Artan Goda, Georges H. Mairesse, Tchavdar Shalganov, Loizos Antoniades, Miloš Táborský,
Giuseppe Boriani, M Vitolo, Marco Proietti, V L Malavasi, N Bonini, G F Romiti, J F Imberti, L Fauchier, Michael Näbauer, Tatjana Potpara, Gheorghe‐Andrei Dan, Zbigniew Kalarus, Aldo Maggioni, Deirdre A. Lane, G Y H Lip
Marrco Vitolo, Vincenzo Livio Malavasi, Marco Proietti, Igor Diemberger, Laurent Fauchier, Francisco Marı́n, Michael Näbauer, Tatjana Potpara, Gheorghe‐Andrei Dan, Zbigniew Kalarus, Luigi Tavazzi, Aldo P. Maggioni, Deirdre A. Lane, Professor Gregory Lip, Giuseppe Boriani
Discussion(0)
No comments yet. Be the first to comment.